jlagasse

Author's posts

Health organizations are embracing emerging technologies, but have to do more amidst changing consumer expectations

Consumer and employee expectations are changing, requiring continued investment in technology from health leaders.

Partners HealthCare ending bid to acquire Care New England Health System

The Rhode Island governor has asked Lifespan, Care New England and Brown University to resume negotiations for an academic medical center.

Consumers and physicians say convenience must be the foundation of any health strategy

Consumers are also interested in technologies that will help them manage their health and engage with physicians.

Hospital drug diversion could play a role in the opioid crisis, research finds

The majority of providers are concerned about drug diversion in hospitals, but only 20 percent believe diversion is cause for concern where they work.

Prescription drug costs steadily soar, while price transparency is lacking

The current rebate system plays a central role driving up costs for consumers, preventing them from making informed decisions, study says.

Hospital boards seeing low turnover, but lack diversity and succession planning

Most hospital board members are male and white, and younger members are rare, but some of these trends are changing.

Value-based care: Is it working?

During June, HFN will dive into the new payments, interview experts and report on what’s really happening with value-based care.

First states to expand Medicaid saw larger screening rate increases

An additional 355,184 people would have been screened for colorectal cancer if non-expansion states had seen the same increases in screenings.

Members want to hear from their health plans more regularly, survey shows

Fewer than one in five are currently receiving information on how to avoid, manage, or mitigate the effects of a costly condition.

Precision medicine as a way to improve oncology care — and potentially drive down drug costs

Targeted interventions have shown a modest ability to lower costs and have the potential to greatly improve cancer care.